A retrospective cohort study comparing the efficacy of Ticagrelor vs Clopidogrel in patients with Acute Coronary Syndrome in USA
Latest Information Update: 14 Dec 2020
Price :
$35 *
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 14 Dec 2020 New trial record
- 17 Nov 2020 Results presented at the American Heart Association Scientific Sessions 2020